688202: Shanghai Medicilon Inc. - Summary | Jitta

Shanghai Medicilon Inc.

CHN:688202

Price
CN¥83.20
Loss Chance
50.9%
3.64JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
134 / 486
1,405 / 5,265
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (52)
Recent Business Performance (77)
Financial Strength (60)
Return to Shareholders (20)
Competitive Advantage (40)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
CapExVery High
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
3.64
100.00%
4.23
> 1,000%
Life Sciences Tools and Services
4.93
> 1,000%
6.58
342.39%
7.67
1.41%
COMPANY DESCRIPTION
Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. The company operates in Drug Discovery and Pharmaceutical Research, and Preclinical Research segments. It offers drug discovery, CMC development, preclinical research, biology, chemistry, catalyst screening, flow chemistry, carbohydrate chemistry, analytical chemical, ADME/DMPK, pharmacology, safety assessment, IND-Enabling studies, and advanced technology services. The company also provides peptide, SiRNA, ADC, Protac, AOCs, NAMs Platforms. The company was founded in 2004 and is based in Shanghai, China.